Inhalational anaesthesia

Current Opinion in Anaesthesiology

Volumn 14, Issue 4, 2001, Pages 387-392

  Bedi, Amit ^a,b   Howard Fee, J P ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b Department of Anaesthetics and Intensive Care Medicine ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABSORBENT; ALKENE DERIVATIVE; CARBON MONOXIDE; CENTRAL DEPRESSANT AGENT; DESFLURANE; HALOTHANE; HYDROXIDE; INHALATION ANESTHETIC AGENT; ISOFLURANE; NITROUS OXIDE; ONDANSETRON; REMIFENTANIL; SEVOFLURANE; XENON;

AGITATION; AIRWAY; ANESTHESIA INDUCTION; CARDIOVASCULAR EFFECT; CHILD; DRUG DEGRADATION; HUMAN; INHALATION ANESTHESIA; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SYMPATHETIC TONE;

EID: 0034929079     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-200108000-00002     Document Type: Review

References (59)

1. Putting the brakes on anesthetic breakdown
2. 2 absorbents during low-flow anesthesia in surgical patients
3. Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers
4. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers
5. Absence of renal and hepatic toxicity after four hours of 1.25 minimum alveolar anesthetic concentration sevoflurane anesthesia in volunteers
6. Compound A concentration is decreased by cooling anaesthetic circuit during low-flow sevoflurane anaesthesia
7. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia
8. Effect of total flow rate on the concentration of degradation products generated by reaction between sevoflurane and soda lime
9. Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents
10. Evaluation of the PhysioFlex closed-circuit anaesthesia machine
11. Amsorb: A new carbon dioxide absorbent for use in anesthetic breathing systems
12. Absorbents differ enormously in their capacity to produce compound A and carbon monoxide
13. The use of lithium hydroxide for carbon dioxide absorption prevents formation of compound A during sevoflurane anesthesia
14. Molecular sieves: An alternative method of carbon dioxide removal which does not generate compound A during simulated low-flow sevoflurane anaesthesia
15. Induction, recovery, and safety characteristics of sevoflurane in children undergoing ambulatory surgery. A comparison with halothane
16. Sevoflurane for ENT-surgery in children. A comparison with halothane
17. Sevoflurane causes more postoperative agitation in children than does halothane
18. Emergence agitation in paediatric patients after sevoflurane anaesthesia and no surgery: A comparison with halothane
19. Quality of recovery in children: Sevoflurane versus propofol
20. Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia
21. Effects of sevoflurane anaesthesia on recovery in children: A comparison with halothane
22. Epileptiform discharges during 2 MAC sevoflurane anesthesia in two healthy volunteers
23. Seizure-like activity on emergence from sevoflurane anesthesia
24. The epileptogenic properties of the volatile anesthetics sevoflurane and isoflurane in patients with epilepsy
25. The sevoflurane-sparing effect of nitrous oxide: A clinical study
26. The pharmacology of sevoflurane in infants and children
27. 2O than with sevoflurane alone
28. Anesthetic doses blocking adrenergic (stress) and cardiovascular responses to incision: MAC BAR
29. Anesthetic doses of sevoflurane to block cardiovascular responses to incision when administered with xenon or nitrous oxide
30. Sevoflurane-nitrous oxide anaesthesia supplemented with remifentanil: Effect on recovery and cognitive function
31. A review of recovery from sevoflurane anaesthesia: Comparisons with isoflurane and propofol including meta-analysis
32. Determination of sevoflurane alveolar concentration for tracheal intubation with remifentanil, and no muscle relaxant
33. Target-controlled propofol vs. sevoflurane: A double-blind, randomised comparison in day-case anaesthesia
34. Postoperative nausea and vomiting after sevoflurane with or without ondansetron compared with propofol in female patients undergoing breast surgery
35. New inhalation agents in paediatric anaesthesia
36. Comparison of sevoflurane and halothane for outpatient dental anaesthesia in children
37. Cardiovascular effects of sevoflurane, isoflurane, halothane and fentanyl-midazolam in children with congenital heart disease
38. Comparison of inhalation induction with 2%, 4%, 6%, and 8% sevoflurane in nitrous oxide for pediatric patients
39. Induction characteristics with 3% and 8% sevoflurane in adults: An evaluation of the second stage of anaesthesia and its haemodynamic consequences
40. Sevoflurane versus propofol for anesthetic induction: A meta-analysis
41. Clinical comparison of 'single agent' anaesthesia with sevoflurane versus target controlled infusion of propofol
42. Clinical impressions and cardiorespiratory effects of a new fluorinated inhalation anaesthetic, desflurane (I-653), in volunteers
43. Absence of bronchodilation during desflurane anesthesia: A comparison to sevoflurane and thiopental
44. Protective effects of volatile agents against methacholine-induced bronchoconstriction in rats
45. The effect of humidification and smoking habit on the incidence of adverse airway events during deepening of anaesthesia with desflurane
46. Intravenous opioids reduce airway irritation during induction of anaesthesia with desflurane in adults
47. Which is most pungent: Isoflurane, sevoflurane or desflurane?
48. High concentrations of isoflurane do not block the sympathetic nervous system activation from desflurane
49. Fatal cardiac ischaemia associated with prolonged desflurane anaesthesia and administration of exogenous catecholamines
50. Desflurane-mediated sympathetic activation occurs in humans despite preventing hypotension and baroreceptor unloading
51. Mechanistic aspects of carbon monoxide formation from volatile anesthetics
52. Physical factors affecting the production of carbon monoxide from anesthetic breakdown
53. Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and baralyme
54. Cause of CO poisoning, relation to halogenated agents still not clear
55. High carboxyhemoglobin concentrations occur in swine during desflurane anesthesia in the presence of partially dried carbon dioxide absorbents
56. Severe carbon monoxide poisoning during desflurane anesthesia
57. Reduction in the incidence of carbon monoxide exposures in humans undergoing general anesthesia
58. Comparison of adenosine and remifentanil infusions as adjuvants to desflurane anesthesia
59. The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery